These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8338871)

  • 1. Musings on the struggle--Part II: The N2-TIL protocol.
    Anderson WF
    Hum Gene Ther; 1993 Jun; 4(3):237-8. PubMed ID: 8338871
    [No Abstract]   [Full Text] [Related]  

  • 2. Musings on the struggle--Part V: Beginning the N2/TIL protocol.
    Anderson WF
    Hum Gene Ther; 1994 Apr; 5(4):427-8. PubMed ID: 8049300
    [No Abstract]   [Full Text] [Related]  

  • 3. The N2-TIL human gene transfer clinical protocol.
    Hum Gene Ther; 1990; 1(1):73-92. PubMed ID: 2081189
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study.
    Freedman RS; Platsoucas CD; Deisseroth AB
    Hum Gene Ther; 1996 Jul; 7(11):1351-65. PubMed ID: 8818723
    [No Abstract]   [Full Text] [Related]  

  • 5. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
    Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
    Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy for the treatment of inborn errors of metabolism].
    Pérez-López J
    Med Clin (Barc); 2014 Jun; 142(12):549-53. PubMed ID: 23932565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF/TIL human gene therapy clinical protocol.
    Hum Gene Ther; 1990; 1(4):441-80. PubMed ID: 2078586
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy for inborn errors of liver metabolism.
    Brunetti-Pierri N; Lee B
    Mol Genet Metab; 2005; 86(1-2):13-24. PubMed ID: 16154372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.
    Hwu P; Yannelli J; Kriegler M; Anderson WF; Perez C; Chiang Y; Schwarz S; Cowherd R; Delgado C; Mulé J
    J Immunol; 1993 May; 150(9):4104-15. PubMed ID: 8473752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene of resistance to neomycin.
    Favrot MC; Philip T
    Hum Gene Ther; 1992 Oct; 3(5):533-42. PubMed ID: 1420452
    [No Abstract]   [Full Text] [Related]  

  • 12. Musings on the struggle--Part IV: Aftermath of the RAC meeting.
    Anderson WF
    Hum Gene Ther; 1993 Oct; 4(5):555-6. PubMed ID: 8280793
    [No Abstract]   [Full Text] [Related]  

  • 13. Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor.
    Donia M; Larsen SM; Met O; Svane IM
    Cytotherapy; 2014 Aug; 16(8):1117-20. PubMed ID: 24831841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
    Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Schallmach E; Kubi A; Shalmon B; Hardan I; Catane R; Segal E; Markel G; Apter S; Nun AB; Kuchuk I; Shimoni A; Nagler A; Schachter J
    J Immunother; 2009 May; 32(4):415-23. PubMed ID: 19342963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemia children and their parents.
    Zimmer J; Khalifa AS; Lightbody JJ
    Cancer Res; 1975 Jan; 35(1):68-70. PubMed ID: 1053696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into human epidermis as an experimental model for somatic gene therapy.
    Jensen TG
    Dan Med Bull; 2004 May; 51(2):155-66. PubMed ID: 16009054
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
    Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
    Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
    Weber J; Atkins M; Hwu P; Radvanyi L; Sznol M; Yee C;
    Clin Cancer Res; 2011 Apr; 17(7):1664-73. PubMed ID: 21325070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.